The medical management of masseteric hypertrophy with botulinum toxin.
The authors present a series of cases of masseteric hypertrophy with associated muscular facial pain treated with botulinum toxin.
Finn
S
S
Department of Oral Surgery, Dental School and Hospital, Wilton, Cork.
Ryan
P
P
Sleeman
D
D
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D005146:Facial Asymmetry / Q000628:therapy; D005157:Facial Pain / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006984:Hypertrophy; D007273:Injections, Intramuscular; D008406:Masseter Muscle / Q000473:pathology*; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A